SR ONE

sr-one-logo

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested approximately 800 million in more than 180 companies.

#SimilarOrganizations #People #Financial #More

SR ONE

Social Links:

Industry:
Finance Financial Services Health Care Venture Capital

Founded:
1985-01-01

Status:
Active

Contact:
(610) 567-1000

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Content Delivery Network LetsEncrypt Amazon SSL By Default HSTS Nginx


Similar Organizations

alexandria-venture-investments-logo

Alexandria Venture Investments

Alexandria Venture Investments is a venture capital firm that develops the work in real estate technology, and healthcare sectors.

100x-ventures-logo

100x Ventures

100x Ventures is the corporate venture capital arm of 100x Group

caffeinated-capital-logo

Caffeinated Capital

Caffeinated Capital is a technology venture capital firm that partners with founders at the inception stage.

foundation-capital-logo

Foundation Capital

Foundation Capital is a venture capital firm made up of former entrepreneurs and helps companies and businesses grow.

general-catalyst-logo

General Catalyst

General Catalyst is a venture capital firm that provides early-stage and growth equity investments.

highland-capital-partners-logo

Highland Capital Partners

Highland Capital Partners is a venture capital firm that offers seed, early, and growth-stage funding solutions.

nexus-venture-partners-logo

Nexus Venture Partners

Nexus Venture Partners is a venture capital firm established by ex-entrepreneurs in enterprise technology and consumer internet.

pfizer-venture-investments-logo

Pfizer Venture Investments

Pfizer Venture Investments is a venture capital firm.

union-square-ventures-logo

Union Square Ventures

Union Square Ventures is a venture capital firm that focuses on early-stage, growth-capital, late-stage, and startup financing.

vivo-capital-logo

Vivo Capital

Vivo is a global investment firm focused on healthcare with approximately $5.8 billion in AUM

Current Employees Featured

jens-eckstein_image

Jens Eckstein
Jens Eckstein President @ SR One
President
2011-10-01

matthew-foy_image

Matthew Foy
Matthew Foy Partner @ SR One
Partner
2011-06-01

karen-narolewski-engel_image

Karen Narolewski Engel
Karen Narolewski Engel Partner @ SR One
Partner
2002-01-01

karen-narolewski-engel_image

Karen Narolewski Engel
Karen Narolewski Engel Vice President Operations @ SR One
Vice President Operations
2020-09-01

deborah-harland_image

Deborah Harland
Deborah Harland Venture Partner @ SR One
Venture Partner
2020-09-01

christopher-y-chai_image

Christopher Y. Chai
Christopher Y. Chai Venture Partner @ SR One
Venture Partner
2021-01-01

rajeev-dadoo_image

Rajeev Dadoo
Rajeev Dadoo Partner @ SR One
Partner
2004-01-01

shaun-foy_image

Shaun Foy
Shaun Foy Venture Partner @ SR One
Venture Partner
2017-05-01

jill-carroll_image

Jill Carroll
Jill Carroll Partner @ SR One
Partner
2011-09-01

simeon-george_image

Simeon George
Simeon George Chief Executive Officer @ SR One
Chief Executive Officer
2020-09-01

Investments List

Date Company Article Money raised
2024-07-17 Renalys Pharma SR One investment in Series A - Renalys Pharma 6 B JPY
2024-07-16 Asceneuron SR One investment in Series C - Asceneuron 100 M USD
2024-06-27 Kala Pharmaceuticals SR One investment in Post-IPO Equity - Kala Pharmaceuticals 12.5 M USD
2024-05-07 Zenas BioPharma SR One investment in Series C - Zenas BioPharma 200 M USD
2024-03-25 Nkarta Therapeutics SR One investment in Post-IPO Equity - Nkarta Therapeutics 240 M USD
2024-03-14 MISSION Therapeutics SR One investment in Series D - MISSION Therapeutics 25.2 M GBP
2024-03-06 Alumis SR One investment in Series C - Alumis 259 M USD
2024-02-13 CRISPR Therapeutics SR One investment in Post-IPO Equity - CRISPR Therapeutics 280 M USD
2023-12-05 Odyssey Therapeutics SR One investment in Series C - Odyssey Therapeutics 101 M USD
2023-09-27 Avalyn Pharma SR One investment in Series C - Avalyn Pharma 175 M USD

More informations about "SR One"

SR One - Crunchbase Investor Profile & Investments

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested …See details»

Matthew R. Patterson - SR One

He also served as a member of the Board of Directors of the Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cell therapy and …See details»

SR One Capital Management investment portfolio - PitchBook

SR One Capital Management's latest investment was on 10-Jan-2025 in Windward Bio, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. …See details»

Chris Chai - SR One

Biotech companies go through numerous transformative events including pre-clinical to clinical, privately held to publicly traded, and importantly R&D to a commercial organization. We are …See details»

SR One - Investments, Portfolio & Company Exits - Crunchbase

SR One 's most notable exits include Alumis, Mineralys Therapeutics, and CalciMedica. Which industries has this organization had the most exits in? Show . Alumis Alumis is a precision …See details»

VC Firm SR One Closes $600M Fund to Build ‘Elite Biotechnology ...

Mar 27, 2023 SR One’s new investment fund is its second one since spinning out of GSK in 2020. The firm says it now has more than $1.5 billion in assets under management. By Frank …See details»

VC firm SR One completes GSK spin-out, raising $500m

Nov 19, 2020 Trans-Atlantic biotech venture capital firm SR One has completed its spin-out from GlaxoSmithKline and closed its first fund with $500m in its coffers. The VC built itself a considerable ...See details»

SR One Company Profile - Office Locations, Competitors ... - Craft

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly …See details»

SR One - Funding, Financials, Valuation & Investors - Crunchbase

Mar 27, 2023 SR One has raised a single venture fund, SR One Fund II. This fund was announced on Mar 27, 2023 and raised a total of . obfuscated. obfuscated. Announced Date . …See details»

News at SR One - The Official Board

SR One has 1,559 competitors including BlackRock (United States (USA)), Vanguard (United States (USA)) and Blackstone Group (United States (USA)). Popular M&A news in Fund …See details»

SR One Company Profile | Management and Employees List

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists, and investment partners to seek to build elite biotechnology …See details»

SR One - Waveup

SR One's investment strategy centers on building and supporting elite biotechnology companies through a "back-and-build" approach, providing both financial and operational support to …See details»

SR One breaks off from GlaxoSmithKline, banks $500M fund

Nov 19, 2020 SR One’s new fund comes as seemingly everybody in the VC world is raising life sciences fund. Just last month, Canaan Partners raised $800 million in its 12th fund to back …See details»

After an ‘amazing year,’ SR One raises $600M to fuel more drug …

Mar 27, 2023 Dive Brief: SR One, the former venture arm of GSK, has raised its second fund since spinning out of the pharmaceutical company, announcing Monday a new $600 million …See details»

List of top SR One Portfolio Companies - Crunchbase

Mar 28, 2008 SR One is the corporate venture capital arm of GlaxoSmithKline. This list of organizations invested in by SR One provides data on their funding history, investment …See details»

SR One Capital Management Overview - SignalHire

SR One Capital Management is a transatlantic biotech venture capital firm that seeks to partner with who we believe to be top entrepreneurs, scientists and investment partners in an effort to …See details»

SR One | Institution Profile - Private Equity International

SR One. News, insights, analysis and data. SR One overview. Founded in 1985, SR One is a United States-based investment firm that targets investments in life science companies. AUM. …See details»

Find Care for Aging Parents | Senior.One

“Senior.One has saved me so much time from independently searching the web for different care providers and having to organize them all on my own. ... “The organization within the …See details»

Senior Organization Effectiveness Professional-Remote US in …

Apply for Senior Organization Effectiveness Professional-Remote US job with Humana in Remote, Nationwide. Human Resources at HumanaSee details»

SR One - Contacts, Employees, Board Members, Advisors

SR One has 11 current employee profiles, including President Jens Eckstein. Contacts. Edit Contacts Section. Job Department. Protected Content. Principal. Director. 1 phone number …See details»

linkstock.net © 2022. All rights reserved